What does CUSIP 03969K108 represent in this 13F holders report?

CUSIP 03969K108 is the security identifier for ARQT - Arcutis Biotherapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ARQT - Arcutis Biotherapeutics, Inc. - Common Stock in Q2 2022?

112 institutional investors reported ARQT - Arcutis Biotherapeutics, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Arcutis Biotherapeutics, Inc. - Common Stock (ARQT)

CUSIP: 03969K108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 122,541,881
Total 13F shares: 49,075,739
Share change: +789,414
Total reported value: $1,045,833,934
Put/Call ratio: 44%
Price per share: $21.31
Number of holders: 112
Value change: +$17,642,019
Number of buys: 70
Number of sells: 31

Quarterly Holders Quick Answers

What is CUSIP 03969K108?
CUSIP 03969K108 identifies ARQT - Arcutis Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 03969K108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ARQT - Arcutis Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Frazier Life Sciences Management, L.P.	13F	Company	6.9%	8,434,232	$162,443,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	6.2%	7,557,593	$145,558,000	—	31 Mar 2022	13F
ORBIMED ADVISORS LLC	13F 3/4/5	Company · 10%+ Owner	5%	6,073,850	$116,982,000	—	31 Mar 2022	13F 3/4/5
BlackRock Finance, Inc.	13F	Company	3.5%	4,315,802	$83,124,000	—	31 Mar 2022	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	3.2%	3,979,292	$76,641,000	—	31 Mar 2022	13F
Polar Capital Holdings Plc	13F	Company	1.5%	1,784,005	$34,360,000	—	31 Mar 2022	13F
Point72 Asset Management, L.P.	13F	Company	1.4%	1,697,849	$32,701,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	1.2%	1,531,098	$29,489,000	—	31 Mar 2022	13F
Logos Global Management LP	13F	Company	1.2%	1,500,000	$28,890,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.97%	1,189,500	$22,910,000	—	31 Mar 2022	13F
EcoR1 Capital, LLC	13F	Company	0.73%	895,503	$17,247,000	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.54%	659,816	$12,708,000	—	31 Mar 2022	13F
Omega Fund Management, LLC	13F	Company	0.51%	623,836	$12,015,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.5%	609,648	$11,741,000	—	31 Mar 2022	13F
Pivotal bioVenture Partners Investment Advisor LLC	13F	Company	0.46%	569,041	$10,960,000	—	31 Mar 2022	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.43%	524,559	$10,103,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.42%	509,381	$9,810,000	—	31 Mar 2022	13F
Ensign Peak Advisors, Inc	13F	Company	0.4%	495,450	$9,544,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.37%	448,702	$8,642,000	—	31 Mar 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.35%	430,262	$8,285,000	—	31 Mar 2022	13F
AXA S.A.	13F	Company	0.29%	354,943	$6,836,202	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.21%	258,937	$4,987,000	—	31 Mar 2022	13F
MPM BioImpact LLC	13F	Company	0.21%	258,500	$4,979,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.19%	227,383	$4,378,000	—	31 Mar 2022	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	0.18%	219,136	$4,221,000	—	31 Mar 2022	13F
GW&K Investment Management, LLC	13F	Company	0.17%	212,500	$4,093,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.16%	200,964	$3,871,000	—	31 Mar 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.15%	189,363	$3,647,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.18%	216,380	$3,568,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.14%	176,700	$3,403,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.11%	138,735	$2,672,000	—	31 Mar 2022	13F
Tekla Capital Management LLC	13F	Company	0.11%	131,633	$2,535,000	—	31 Mar 2022	13F
Neuberger Berman Group LLC	13F	Company	0.11%	129,276	$2,490,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.08%	100,126	$1,928,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.08%	97,441	$1,878,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.08%	96,346	$1,856,000	—	31 Mar 2022	13F
HSBC HOLDINGS PLC	13F	Company	0.08%	91,988	$1,773,000	—	31 Mar 2022	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.07%	87,369	$1,683,000	—	31 Mar 2022	13F
Walleye Capital LLC	13F	Company	0.06%	75,553	$1,455,000	—	31 Mar 2022	13F
1492 Capital Management LLC	13F	Company	0.06%	75,192	$1,448,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.05%	62,573	$1,205,000	—	31 Mar 2022	13F
NORGES BANK	13F	Company	0.05%	61,116	$1,177,094	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.05%	59,500	$1,146,000	—	31 Mar 2022	13F
Rafferty Asset Management, LLC	13F	Company	0.05%	57,259	$1,103,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.04%	54,302	$1,046,000	—	31 Mar 2022	13F
HAMILTON LANE ADVISORS LLC	13F	Company	0.04%	52,347	$1,008,000	—	31 Mar 2022	13F
ALPS ADVISORS INC	13F	Company	0.04%	51,783	$997,000	—	31 Mar 2022	13F
BARCLAYS PLC	13F	Company	0.03%	37,938	$730,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	35,340	$681,000	—	31 Mar 2022	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	33,524	$646,000	—	31 Mar 2022	13F

Institutional Holders of Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) as of Q2 2022

As of 30 Jun 2022, Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) was held by 112 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,075,739 shares. The largest 10 holders included Frazier Life Sciences Management, L.P., FMR LLC, ORBIMED ADVISORS LLC, BlackRock Inc., Bain Capital Life Sciences Investors, LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, Polar Capital Holdings Plc, STATE STREET CORP, and Logos Global Management LP. This page lists 112 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

106

Q2 2022 holders

112

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.